A novel bis-phenanthridine triamine with pH controlled binding to nucleotides and nucleic acids

Organic and Biomolecular Chemistry

Volumn 3, Issue 24, 2005, Pages 4373-4381

  Malojčić, Goran ^a,c   Piantanida, Ivo ^a   Marinić, Mima ^a   Žinić, Mladen ^a   Marjanović, Marko ^a   Kralj, Marijeta ^a   Pavelić, Krešimir ^a   Schneider, Hans Jörg ^b  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b SAARLAND UNIVERSITY   (Germany)

^c ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADDITION REACTIONS; COMPLEXATION; DERIVATIVES; DNA; PH EFFECTS; RNA; TOXICITY;

BIS-PHENANTHRIDINE TRIAMINE; CYTOTOXICITY; NUCLEOTIDES; POLYNUCLEOTIDES;

AMINES;

ANTINEOPLASTIC AGENT; NUCLEIC ACID; NUCLEOTIDE; PHENANTHRIDINE DERIVATIVE;

AMINATION; ARTICLE; CELL LINE; CELL PROLIFERATION; CHEMICAL STRUCTURE; CHEMISTRY; DNA DENATURATION; DRUG EFFECT; HUMAN; NONLINEAR SYSTEM; OSMOLARITY; PH; SPECTROSCOPY; TEMPERATURE; TITRIMETRY;

AMINATION; ANTINEOPLASTIC AGENTS; CELL LINE; CELL PROLIFERATION; HUMANS; HYDROGEN-ION CONCENTRATION; MOLECULAR STRUCTURE; NONLINEAR DYNAMICS; NUCLEIC ACID DENATURATION; NUCLEIC ACIDS; NUCLEOTIDES; OSMOLAR CONCENTRATION; PHENANTHRIDINES; SPECTRUM ANALYSIS; TEMPERATURE; TITRIMETRY;

EID: 29844432891     PISSN: 14770520     EISSN: None     Source Type: Journal    
DOI: 10.1039/b509094f     Document Type: Article

References (46)

1. M. Demeunynck, C. Bailly and W. D. Wilson, DNA and RNA binders, Wiley-VCH, Weinheim, 2002.
2. E. J. Fechter, B. Olenyuk and P. B. Dervan, Angew, Chem., Int. Ed., 2004, 43, 3591-3594.
3. L. P. G. Wakelin, Med. Res. Rev., 1986, 6(3), 315-335.
4. K. D. Copeland, M. P. Fitzsimons, R. P. Houser and J. K. Barton, Biochemistry, 2002, 41, 343-356.
5. F. Pina, M. A. Bernardo and E. García-España, Eur. J. Inorg. Chem., 2000, 10, 2143-2157.
6. J. Barbet, B. P. Roques, S. Combrisson and J. B. LePecq, Biochemistry, 1976, 15, 2642-2650;
7. O. Baudoin, F. Gonnet, M.-P. Teulade-Fichou, J.-P. Vigneron, J.-C. Tabet and J.-M. Lehn, Chem. Eur. J., 1999, 5, 2762-2771;
8. N. Berthet, J. Michon, J. Lhomme, M.-P. Teulade-Fichou, J.-P. Vigneron and J.-M. Lehn, Chem. Eur. J., 1999, 5, 3625-3629;
9. M. Jourdan, J. Garcia, J. Lhomme, M.-P. Teulade-Fichou, J.-P. Vigneron and J.-M. Lehn, Biochemistry, 1999, 38, 14205-14213;
10. A. Slama-Schwok, M.-P. Teulade-Fichou, J.-P. Vigneron, E. Taillandier and J.-M. Lehn, J. Am. Chem. Soc., 1995, 117, 6822-6831.
11. M. T. Albelda, M. A. Bernardo, P. Díaz, E. García- España, J. S. de Melo, F. Pina, C. Soriano and S. V. Luis, Chem. Commun., 2001, 1520-1521.
12. M. M. Becker and P. B. Dervan, J. Am. Chem. Soc., 1979, 101, 3664-3666.
13. N. Raghunand and R. J. Gillies, Drug Resist. Updates, 2000, 3, 39-47.
14. T. Eicher and A. Kruse, Synthesis, 1985, 612.
15. L.-M. Tumir, I. Piantanida, P. Novak and M. Žinić, J. Phys. Org. Chem., 2002, 15, 599-607.
16. Specfit Global Analysis, a Program for Fitting, Equilibrium and Kinetic Systems, Using Factor Analysis & Marquardt MinimizationH. Gampp, M. Maeder, C. J. Meyer and A. D. Zuberbuehler, Talanta, 1985, 32, 257-264;
17. M. Maeder and A. D. Zuberbuehler, Anal. Chem., 1990, 62, 2220-2224.
18. P. Čudić, M. Žinić, V Tomišić, V. Simeon, J.-P. Vigneron and J.-M. Lehn, J. Chem. Soc., Chem. Commun., 1995, 1073-1075.
19. A. Odani, H. Masuda, O. Yamauchi and S. Ishiguro, Inorg. Chem., 1991, 30, 4486-4488.
20. I. Piantanida, V. Tomišić and M. Žinić, J Chem. Soc., Perkin Trans. 2, 2000, 375-383.
21. L.-M. Tumir, I. Piantanida, I. Juranović Cindrić, T. Hrenar, Z. Meić and M. Žinić, J . Phys. Org. Chem., 2003, 16, 891-899.
22. G. Scatchard, Ann. N. Y. Acad. Sci., 1949, 51, 660-672;
23. J. D. McGhee and P. H. von Hippel, J. Mol. Biol, 1976, 103, 679-684.
24. H. W. Zimmermann, Angew. Chem., Int. Ed. Engl., 1986, 25, 115-196.
25. M. Cory, D. D. McKee, J. Kagan, D. W. Henry and J. A. Miller, J. Am. Chem. Soc., 1985, 107, 2528-2536.
26. C. R. Cantor and P. R. Schimmel, Biophysical Chemistry, WH Freeman and Co., San Francisco, 1980, vol. 3, pp. 1109-1181.
27. W. D. Wilson, F. A. Tanious, M. Fernandez-Saiz and C. T. Rigl, Evaluation of Drug/Nucleic Acid Interactions by Thermal Melting Curves, from: Methods in Molecular Biology, vol. 90, Drug-DNA Interaction Protocols, ed. K. R. Fox, Humana Press Inc., Totowa, N.Y., 1998.
28. H. C. M. Nelson, J. T. Finch, B. F. Luisi and A. Klug, Nature, 1987, 330, 221-226.
29. W. D. Wilson, Y.-H. Wang, C. R. Krishnamoorthy and J. C. Smith, Biochemistry, 1985, 24, 3991-3999.
30. J. Sartorius and H.-J. Schneider, FEBS Lett., 1995, 374, 387-392.
31. G. Dougherty and J. R. Pilbrow, Int. J. Biochem., 1984, 16, 1179-1192;
32. E. C. Long and J. K. Barton, Acc. Chem. Res., 1990, 23, 273-279.
33. I. Piantanida, B. S. Palm, M. Žinić and H.-J. Schneider, J. Chem. Soc., Perkin Trans. 2, 2001, 1808-1816.
34. J. Kapuscinski and Z. Darzynkiewicz, J. Biomol. Struct. Dyn, 1987, 5, 127-143.
35. W. Saenger, Principles of Nucleic Acid Structure, Springer, New York, 1988, ch. 13.6, pp. 315-320;
36. J. T. Davis, Angew. Chem., 2004, 43, 668-698.
37. S. Georghiou, Photochem. Photobiol, 1977, 26, 59.
38. J. Ramstein and M. Leng, Biochim. Biophys. Acta, 1972, 281, 18.
39. X. Gao and D. J. Patel, Biochemistry, 1988, 27, 1744-1751.
40. Monomer 4 is actually the starting material for the synthesis of 1, and was prepared according to previously described procedures (see Experimental).
41. P. Wong, C. Lee and I. F. Tannock, Clin. Cancer Res., 2005, 11, 3553-3557.
42. J. B. Chaires, N. Dattagupta and D. M. Crothers, Biochemistry, 1982, 21, 3933-3940.
43. B. S. Palm, I. Piantanida, M. Žinić and H.-J. Schneider, J. Chem. Soc., Perkin Trans. 2, 2000, 385-392.
44. M. R. Boyd and K. D. Paull, Drug Dev. Res., 1995, 34, 91-109.
45. I. Jarak, M. Kralj, L. Šuman, G. Pavlović, J. Dogan, I. Piantanida, M. Žinić, K. Pavelić and G. Karminski-Zamola, J. Med. Chem., 2005, 48, 2346-2360.
46. T. Mossman, J. Immunol. Methods, 1983, 65, 55-61.